Aims/hypothesis Increased extracellular matrix (ECM) collagen is a characteristic of muscle insulin resistance. Matrix metalloproteinase (MMP) 9 is a primary enzyme that degrades collagen IV (ColIV). As a component of the basement membrane, ColIV plays a key role in ECM remodelling. We tested the hypotheses that genetic deletion of MMP9 in mice increases muscle ColIV, induces insulin resistance in lean mice and worsens diet-induced muscle insulin resistance. 
Introduction
Insulin resistance is closely associated with extracellular matrix (ECM) remodelling in muscle, such that the deposition of ECM components is increased [1] [2] [3] [4] . Collagens, the most abundant structural components of the ECM, are increased in insulin-resistant muscles of both humans [2] and rodents [3] . Rescue of muscle insulin resistance, either genetically by mitochondria-targeted catalase overexpression or pharmacologically by the phosphodiesterase 5 inhibitor sildenafil, reverses the expression of ECM collagens [3] . This close association between muscle insulin action and ECM collagen remodelling is of great potential significance in the pathogenesis of insulin resistance.
Matrix metalloproteinases (MMPs), a family of zincdependent proteinases, are responsible for the degradation of all components of the ECM [5] . MMPs are synthesised and secreted in a latent form with a pro-domain, and can be activated by the proteolytic cleavage of the pro-domain by other MMPs, proteases or even, on occasion, by the enzyme itself [6] . Because of their potent broad degradative capacity, MMPs play an essential role in regulating ECM turnover and remodelling in both normal physiology and diseases including degenerative eye disease [7] , osteolysis [8] , systemic sclerosis [9] and cancers [10] . Dysregulation of MMPs has also been implicated in the pathophysiology of obesity and diabetes. Plasma concentrations of MMP2 and MMP9, the type IV collagenases, are increased in obese [11] and diabetic [12] individuals. More recently, Tinahones et al reported that gene expression of adipose MMP9 correlates positively with the homeostasis model assessment index in morbidly obese individuals [13] . In contrast to increased MMP9 expression in circulation and adipose tissue of obese individuals, MMP9 activity in skeletal muscle is decreased in high-fat (HF)-fed insulin-resistant mice [3] . This decreased MMP9 activity relates inversely to muscle collagen deposition and directly to muscle insulin resistance [3] . These findings in muscle suggest that muscle expression of MMP9 is responsible for local ECM dynamics. The composition of the ECM has metabolic, haemodynamic, angiogenic and a variety of other effects through its interaction with integrin receptors [3] . It also determines the spatial barrier from endothelium to muscle cell surface.
In the present study, we aimed to test the hypotheses that genetic deletion of MMP9 in mice increases muscle collagens, induces insulin resistance in lean mice and worsens diet-induced muscle insulin resistance. Mice that are homozygous null for the MMP9 gene are viable and fertile [14] . Mmp9 -null mice have been previously characterised in a number of experimental models including tumorigenesis [15] , skeleton formation [14] and cardiovascular [16] , central nervous [17] and immune [18] responses. These are the first experiments to examine the in vivo glucose metabolic fluxes and muscle glucose utilisation in these mice. Mice fed chow or an HF diet (a well-characterised mouse model of insulin resistance [19] ) were used to investigate the role of MMP9 in diet-induced muscle insulin resistance.
Methods
Mouse models Mice were housed under a temperature and humidity controlled environment with a 12 h light/dark cycle. Mice lacking MMP9 (Mmp9 −/− ) were obtained by breeding heterozygous Mmp9-null mice on a C57BL/6 J background (Mmp9 +/− , Stock Number: 007084; the Jackson Laboratory, Bar Harbor, ME, USA). The homozygous Mmp9 -null mice and their wild-type littermate controls (Mmp9 +/+ ) were fed with an HF diet (F3282; BioServ, Frenchtown, NJ, USA) containing 60% of energy intake as fat, or were kept on chow diet starting at 3 weeks of age (at weaning), for 16 weeks. All mice were studied at 19 weeks of age. Body composition was determined by nuclear magnetic resonance spectroscopy. The Vanderbilt Animal Care and Use Committee approved all animal procedures. H y p e r i ns u l i na e m i c-e u g l y ca e m i c c l a m p F o r th e hyperinsulinaemic-euglycaemic clamp (IC v ), catheters were implanted in a carotid artery and a jugular vein of mice for sampling and infusions 5 days before the study [20] . [22] . Glucose appearance (Ra) and disappearance (Rd) rates were determined using non-steadystate equations [23] . Endogenous glucose appearance (EndoRa) was determined by subtracting the GIR from total Ra. The glucose metabolic index (Rg) was calculated as previously described [24] . Indirect calorimetry Energy expenditure, food consumption and physical activity were assessed by the Promethion system (Sable Systems, Las Vegas, NV, USA). Mice were individually housed for a week before the measurements. Indirect calorimetry was measured for 5 consecutive days. Pedestrian distance was determined by the XY array with a 1 cm/s minimum movement cutoff. The mean pedestrian speed was determined with a cutoff point of 10% of the maximum speed found in the cycle. Western blotting Gastrocnemius was homogenised in buffer containing 50 mmol/l Tris-HCl, pH7.5, 1 mmol/l EDTA, 1 mmol/l EGTA, 10% glycerol, 1% Triton X-100, 1 mmol/l dithiothreitol, 1 mmol/l phenylmethylsulfonyl fluoride, 5 μg/ml protease inhibitor, 50 mmol/l NaF, 5 mmol/l sodium pyrophosphate and centrifuged at 17,000g for 20 min at 4°C. Forty microgrammes of the supernatant fluid was applied to a 4%-12% SDS-PAGE gel (Life Technologies). MMP9 was probed using the MMP9 antibody (Abcam).
Gelatin zymography
Vascular endothelial growth factor in muscle The concentration of vascular endothelial growth factor (VEGF) was determined in muscle homogenates using the VEGF ELISA kit (Calbiochem from Millipore, Billerica, MA, USA) as previously described [25, 26] . The kit measures VEGF 120 and VEGF 164 isoforms.
Statistical analysis Data are expressed as mean ± SEM. Statistical analyses were performed using Student's t test or two-way ANOVA followed by Tukey's post hoc tests as appropriate. Analysis of covariance (ANCOVA) was used to test energy expenditure for significance between groups as previously described [27] [28] [29] , using a public web portal developed by the National Mouse Metabolic Phenotyping Centers at www.mmpc.org/shared/regression.aspx (accessed 30 October 2013). Multiple linear regression analysis was used to assess the impact of covariates (body mass, fat mass and lean mass). The significance level was p <0.05.
Results
Protein expression of MMP9 in muscle Genetic deletion of MMP9 abolished protein expression of MMP9 in muscle of chow-and HF-fed mice ( Fig. 1 ). Muscle MMP9 protein was decreased by HF feeding in female Mmp9 +/+ mice, but not in male Mmp9
+/+ mice ( Fig. 1a-c ). Plasma MMP9 activity was increased in HF-fed Mmp9 +/+ mice when compared with healthy lean Mmp9 +/+ mice regardless of sex (Fig. 1d ).
Body weight and body composition of the Mmp9-null mice Chow-fed Mmp9 −/− mice grew similarly to their sex-
b). HF-diet feeding increased body weight gains in both Mmp9
+/+ and Mmp9
mice regardless of sex ( Fig. 2a, b) . In female mice, however, Mmp9 −/− mice gained substantially less weight than their Mmp9 +/+ littermates on an HF diet (Fig. 2a) . In contrast, HF-fed male Mmp9 +/+ and Mmp9 −/− mice had comparable growth curves (Fig. 2b) . Consistent with the same body weight gain in the chow-fed mice, the body composition of the mice was comparable in chow-fed Mmp9 +/+ and Mmp9 −/− mice and their heterozygous (Mmp9 +/− ) littermates at 18 weeks of age (Fig. 2c, d ). The decreased body weight in HF-fed female mmp9 −/− mice was due to decreases in both fat mass and lean mass at 18 weeks of age (Fig. 2e ). HF-fed female Mmp9 +/− mice showed a tendency for decreased body weight, fat mass and lean mass, although the differences did not reach statistical significance ( (Fig. 3a) . ANCOVA further showed that the interaction between covariates (body mass, fat mass and lean mass) and energy expenditure did not significantly differ between genotypes. Model-based statistics showed that energy expenditure (ANCOVA-adjusted group means) during both light and dark cycles was not different between genotypes (see electronic supplementary material [ESM] Table 1 ). RQ was lower in Mmp9 −/− mice during the light cycle but was the same between groups during the dark cycle (Fig. 3b) . The average meal size was not different during the light cycle, but was decreased in the null mice during the dark cycle (Fig. 3c) . The number of meals and total food intake were the same between genotypes (Fig. 3d, e) . Voluntary physical activity, as shown by pedestrian distance during the dark cycle and the mean pedestrian speed during both light and dark cycles, was significantly higher in the female Mmp9 −/− mice than in the female Mmp9 +/+ controls (Fig. 3f, g ).
Insulin action in Mmp9-null mice To determine the role of MMP9 in muscle insulin action, IC v was performed in the Mmp9 −/− mice along with their littermate Mmp9 +/+ controls. As body weight, sex and diet are independent factors determining insulin action, IC v was performed in sex-matched and body weight-matched mice on both chow and HF diets (Table 1) . Although female Mmp9 −/− mice statistically gained less weight during HF feeding compared with their Mmp9
littermates, there was a broad range of overlap in body weights between the two groups of mice (ESM Fig. 1 ). To isolate body weight-independent effects of MMP9 deletion, IC v clamps were performed in mice whose weights fell within the overlapping range (27-37 g, ESM Fig. 1 ). Basal 5 h fasting arterial glucose, insulin and NEFA levels were the same between Mmp9 −/− mice and their body weight-, sex-and diet-matched Mmp9 +/+ littermates (Table 1) . Arterial glucose was clamped at ∼8.5 mmol/l in all groups of mice during the IC v (Table 1 and Figs 4a , e, 5a, e). IC v insulin was elevated equivalently in the Mmp9 −/− mice and their weight-, sex-and diet-matched Mmp9 +/+ controls except that IC v insulin was 30% higher in the chow-fed female Mmp9 −/− mice relative to chow-fed female Mmp9 +/+ mice (Table 1) . NEFA levels were decreased similarly during the IC v in Mmp9 −/− mice and their respective controls ( Table 1) .
The GIR, EndoRa and Rd rates in both basal and insulinclamped states were the same in chow-fed Mmp9 −/− and sexmatched Mmp9 +/+ mice (Fig. 4b, c, f, g ). Insulin-stimulated suppression of EndoRa and insulin-stimulated increase in Rd, calculated by the differences between basal and clamped EndoRa and Rd, did not differ between genotypes in chowfed mice (Fig. 4c, g ). A muscle glucose metabolic index, Rg, was also comparable between chow-fed Mmp9 −/− and sexmatched Mmp9 +/+ mice in both gastrocnemius and superficial vastus lateralis (SVL) (Fig. 4d, h ). These results suggest that MMP9 deletion did not affect insulin action in mice fed a regular rodent chow diet.
In HF-fed mice, the GIR was significantly lower in the Mmp9 −/− mice than in Mmp9 +/+ mice of either sex (Fig. 5b, f) . Consistent with lower GIR, insulin-stimulated increase in Rd during the clamp and muscle Rg in both gastrocnemius and (Fig. 5c, d, g, h) . In contrast, neither EndoRa in basal and insulin-stimulated states nor insulinstimulated suppression of EndoRa during the clamp differed between Mmp9 +/+ and Mmp9 −/− mice (Fig. 5c, g ). These data suggest that MMP9 deletion exacerbated muscle insulin action but did not affect hepatic insulin action in mice fed an HF diet. Rg in adipose tissue was the same when comparing Mmp9 +/+ mice with Mmp9 −/− mice on chow diet, and female HF-fed weight-matched Mmp9 +/+ mice with Mmp9 −/− mice ( Fig. 6a-c) . In contrast, adipose Rg was lower in HF-fed male Mmp9 −/− mice than in HF-fed male Mmp9 +/+ (Fig. 6d) .
Mechanisms of worsened muscle insulin resistance in the HFfed Mmp9-null mice Protein expression of ColIV was (Fig. 7c-f ).
Muscle vascularisation was, however, significantly lower in the HF-fed Mmp9 −/− mice than in HF-fed Mmp9 +/+ controls. HF-diet feeding did not affect muscle vascularisation, regardless of genotype. Sex had no effect on protein staining of ColIV, CD31 or vWF. Data presented in Fig. 7 were collected from pooled female and male mice. MMP9 has been suggested to stimulate the production and secretion of VEGF [30, 31] , a critical angiogenic factor regulating muscle vascularisation and insulin action [25] . However, the muscle VEGF concentration in HF-fed Mmp9 −/− mice did not differ from that in HF-fed Mmp9 +/+ controls (Fig. 7g ).
Discussion
The study shows that MMP9, one of the key enzymes responsible for ECM proteolysis and remodelling, is necessary to protect against a more serious insulin resistance in HF-fed mice. Muscle of lean Mmp9 -null mice utilises glucose These data suggest that ColIV and other MMP9 substrates (e.g. collagen V) do not pose a significant barrier to muscle glucose uptake in the absence of the pathophysiology resulting from HF feeding. We have previously reported that MMP9 activity is decreased in insulinresistant skeletal muscle of HF-fed mice and that normalisation of muscle insulin resistance is associated with rescued MMP9 activity and normalisation of muscle collagen deposition [3] . The current study shows that reduced MMP9 by itself does not create insulin resistance in muscle or liver. When coupled with an HF diet, however, it results in a more profound state of insulin resistance, specifically in skeletal muscle. This is consistent with our previous findings and provides further evidence that ECM turnover is a major component of the metabolic regulation of skeletal muscle in the pathology of diet-induced insulin resistance. It has been shown previously that MMP9 deficiency causes abnormal growth plate development; however, after 3 weeks of age, aberrant apoptosis, vascularisation and ossification compensate to remodel the enlarged growth plate and ultimately produce an axial skeleton of normal appearance [14] . Despite this transient skeleton phenotype, we found that genetic deletion of MMP9 did not affect the weight gain of lean mice up to 18 weeks of age. In the presence of HF diet, however, MMP9 deletion prevented HF diet-induced obesity and adiposity in female mice, but not in the male mice. These results suggest that MMP9 may interact with sex hormones (e.g. oestrogen in the regulation of adiposity) to create sexual dimorphisms. This interaction is demonstrated by the fact that oestrogen causes a dose-dependent increase in the gene . n =6 for both female and male mice. *p <0.05, compared with Mmp9 +/+ mice; † p <0.05 comparing genotype; ‡ p =0.06, compared with Mmp9 +/+ mice expression of MMP9 [32] . Furthermore, MMP9 protein was decreased in female mice after HF feeding, but not in the male mice, further suggesting that MMP9 exhibits sexually dimorphic responses in the presence of HF-diet feeding. Further, energy balance measurement shows that the prevention of HF diet-induced obesity and adiposity in the female null mice is associated with decreased average meal size and increased physical activity. However, differences in total food intake and energy expenditure were not manifested at the time of measurement before the body weight of the null mice statistically diverged from the controls. We postulate that decreased average meal size and increased physical activity in the null mice would lead to decreased food intake and increased energy expenditure after prolonged HF feeding (>6 weeks), which would contribute to decreased body weight gain in the female Mmp9 −/− mice. Decreased RQ in the null mice during the light cycle suggests that the female null mice preferentially use fat as fuels during the light cycle when food consumption is low, which may also lead to decreased adiposity in these mice.
The differential responses to diet suggest that impaired muscle ECM remodelling due to MMP9 deletion has to be accompanied by HF diet-induced metabolic and/or inflammatory responses to regulate muscle insulin action. HF-diet feeding in mice is a well-established model of muscle insulin resistance [33] , which is largely mediated by the macrophageinduced proinflammatory actions including elevated cytokine expression in the muscle [34] . It is possible that elevated cytokines in the muscle during an HF diet interact with ECM components such as integrins and MMPs [35] activating signal transduction cascades that regulate substrate transport.
Moreover, cytokines are also involved in regulating the processing of MMPs from inactive zymogens to active enzymes and regulate interstitial collagen gene expression [36, 37] .
Body weight and body composition are important factors affecting the action of insulin in mice. The per cent lean mass was higher in HF-fed female Mmp9 −/− mice than in HF-fed female Mmp9 +/+ mice (Fig. 2h) . In the weight-matched Mmp9 +/+ and Mmp9 −/− mice, lean mass if different would be greater in the null mice. These data confirm that exacerbated insulin resistance in weight-matched HF-fed female Mmp9 −/− mice was not due to decreased lean mass. This, in fact, would indicate that the Mmp9 −/− mice were more insulin resistant per unit of lean mass. Results from clamp experiments in HF-fed female mice, in which genotypes were weight matched, were consistent with HF-fed male mice, which as a group exhibited no difference in body weight. Exacerbated muscle insulin resistance in the HF-fed Mmp9 −/− mice was associated with a significant reduction in the numbers of CD31-positive structures and areas of vWFpositive structures, both of which are endothelial markers. We postulate that one of the potential mechanisms by which MMP9 deletion worsens HF diet-induced muscle insulin resistance is impairment of capillary numbers. It has been suggested that impaired capillary density may be a cause of insulin resistance and type 2 diabetes [38] [39] [40] . In addition to the number of capillaries Kubota et al have shown that impaired insulin signalling in endothelial cells, due to reduced Irs2 expression and insulin-induced endothelial nitric oxide synthase phosphorylation, reduces insulin-stimulated glucose uptake by skeletal muscle in both ob/ob and HF diet-fed mice [41] . This was demonstrated by reduced in vivo skeletal muscle glucose uptake during the IC v in endothelial Irs2-null mice, whereas ex vivo glucose uptake in isolated skeletal muscle, where muscle cells are freely accessible to insulin and glucose, was not impaired [41] . Our results are also strongly supported by a previous study in mice showing that Mmp9-null hypertrophic cartilage exhibits no angiogenic response in a collagen gel co-culture with endothelial cells in an in vitro angiogenesis assay [14] . The mechanism by which MMP9 stimulates angiogenesis has been suggested to be via the stimulation of production and secretion of VEGF [30, 31] . VEGF is a critical angiogenic factor regulating muscle vascularisation and insulin action as muscle specific deletion of VEGF induces muscle capillary rarefaction and muscle insulin resistance in healthy lean mice [25] . However, muscle VEGF concentration was the same between HF-fed wildtype and Mmp9-null mice. Taken together, these results suggest that MMP9 regulates the myocellular response to insulin in HF-fed mice possibly by regulating muscle vascularisation and potential regulation of perfusion by a mechanism independent of VEGF expression. In addition to being diet specific, the effects of MMP9 deletion on insulin sensitivity also appear to be tissue specific. There were no effects observed on hepatic insulin action in the HF-fed Mmp9 −/− mice. The ability of insulin to suppress hepatic glucose production was the same in HF-fed Mmp9 +/+ and HF-fed Mmp9 −/− mice during the IC v . This is not surprising since our data suggest that the major site of action of MMP9 is potentially in the endothelium. The liver was not affected, possibly due to the fact that the liver has fenestrated sinusoidal endothelial cells [42, 43] and therefore is possibly less susceptible to dysfunctional endothelium. While the ability of insulin to suppress plasma NEFA levels was not affected, adipose tissue glucose uptake was decreased in the HF-fed male Mmp9 −/− mice. These results further emphasise the importance of MMP9 to metabolic processes. We were the first to report a paradox such that plasma MMP9 activity increases while muscle MMP9 decreases in HF diet-induced insulin resistance in mice [3] . We hypothesised that the reduction in muscle MMP9 contributes to the accumulation of basement membrane collagen (ColIV) and the ECM maladaptations to HF diet. The question as to whether the observed effects are due to the whole-body absence of MMP9 or a further reduction in muscle MMP9 is impossible to ascertain. It is notable, however, that the muscle was the specific site where insulin resistance was worsened (i.e. hepatic glucose production and arterial NEFA concentrations were unaffected). Thus it seems reasonable to conclude that elimination of MMP9 specifically at the site of dysfunction is primary to the exacerbation of insulin resistance.
In conclusion, our study demonstrates for the first time a critical role of MMP9 in the regulation of ECM remodelling, muscle capillaries and muscle glucose uptake in response to insulin in the presence of HF-diet feeding. These results are consistent with previous studies in humans highlighting the [44] but are currently considered as a therapy for inflammatory and vascular diseases [45] . The results of the present study provide evidence that the therapeutic application of MMP inhibitors may have adverse effects on insulin action.
